KB

Krzysztof Brzozka

Chief Scientific Officer, Executive Vice President

Ryvu Therapeutics

Krakow, Lesser Poland Voivodeship


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Ryvu Therapeutics
Industry
biotechnology
Employees
250.0
Seniority
C suite
Annual Revenue
19218000.0

Technologies

Cloudflare DNS Outlook CloudFlare Hosting WordPress.org YouTube SALESmanago Shutterstock Google Maps Mobile Friendly Google Tag Manager Google Maps (Non Paid Users) reCAPTCHA

Keywords

oncology drug discovery biotech kinase inhibitor cancer metabolism immunooncology aml hrmds synthetic lethality drug development therapeutics clinical trials immuno-oncology kinase inhibitors cdk8/cdk19 acute myeloid leukemia high-risk myelodysplastic syndromes solid tumors venetoclax pim kinase flt3 kinase small molecule therapies scientific research cancer treatment patient care innovation pharmaceuticals collaborations clinical studies research partnerships targeted therapy hematological malignancies cancer drug development preclinical models translational research life sciences medical research patient recruitment biopharmaceuticals therapeutic candidates novel therapies personalized medicine investor relations regulatory strategy disease progression therapy resistance drug efficacy biotechnology industry licensed compounds investor communications pipeline candidates scientific publications clinical endpoints drug safety patient outcomes clinical-stage biopharmaceutical oncology therapies precision medicine myelodysplastic syndromes rvu120 cdk8/cdk19 inhibitor dual pim/flt3 inhibitor antibody-drug conjugates onco prime platform emerging targets patient-focused healthcare professionals global partnerships biopharmaceutical industry cancer patients innovative treatments therapeutic mechanisms oncology market collaborative approach financial performance strategic initiatives competitive landscape hospital & health care health care health wellness & fitness medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans